Pharmaceutical patent grants in India (2009-2016) which relate to process claims.

For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.

A61K patent grants in India (2009-2016) which do not relate to pharmaceuticals, comprising herbal medicines (302), cosmetics (233), dental products (70), and other unrelated categories (265).

For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.

Pharmaceutical patent grants in India (2009-2016) for which there is insufficient data in the Indian Patent Office records.

For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.

Pharmaceutical patent applications rejected by the Indian Patent Office (2009-2016).xls

For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Rejected in India: What the Indian Patent Office got Right on pharmaceuticals patent applications (2009–2016).

Pharmaceutical patent applications rejected by the Indian Patent Office (2009-2016).ods

For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Rejected in India: What the Indian Patent Office got Right on pharmaceuticals patent applications (2009–2016).